GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bionoid Pharma Inc (OTCPK:BINP) » Definitions » Enterprise Value

Bionoid Pharma (Bionoid Pharma) Enterprise Value : $13.50 Mil (As of May. 17, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Bionoid Pharma Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bionoid Pharma's Enterprise Value is $13.50 Mil. Bionoid Pharma's EBIT for the trailing twelve months (TTM) ended in Mar. 2011 was $-9.08 Mil. Therefore, Bionoid Pharma's EV-to-EBIT ratio for today is -1.49.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Bionoid Pharma's Enterprise Value is $13.50 Mil. Bionoid Pharma's EBITDA for the trailing twelve months (TTM) ended in Mar. 2011 was $-9.04 Mil. Therefore, Bionoid Pharma's EV-to-EBITDA ratio for today is -1.49.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Bionoid Pharma's Enterprise Value is $13.50 Mil. Bionoid Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2011 was $0.00 Mil. Therefore, Bionoid Pharma's EV-to-Revenue ratio for today is .


Bionoid Pharma Enterprise Value Historical Data

The historical data trend for Bionoid Pharma's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionoid Pharma Enterprise Value Chart

Bionoid Pharma Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10
Enterprise Value
- 13.19 8.41 5.40 21.26

Bionoid Pharma Quarterly Data
Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.35 7.36 13.43 21.26 20.24

Competitive Comparison of Bionoid Pharma's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Bionoid Pharma's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bionoid Pharma's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bionoid Pharma's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Bionoid Pharma's Enterprise Value falls into.



Bionoid Pharma Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Bionoid Pharma's Enterprise Value for the fiscal year that ended in Dec. 2010 is calculated as

Bionoid Pharma's Enterprise Value for the quarter that ended in Mar. 2011 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bionoid Pharma  (OTCPK:BINP) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Bionoid Pharma's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=13.499/-9.076
=-1.49

Bionoid Pharma's current Enterprise Value is $13.50 Mil.
Bionoid Pharma's EBIT for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.08 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Bionoid Pharma's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=13.499/-9.041
=-1.49

Bionoid Pharma's current Enterprise Value is $13.50 Mil.
Bionoid Pharma's EBITDA for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.04 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Bionoid Pharma's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=13.499/0
=

Bionoid Pharma's current Enterprise Value is $13.50 Mil.
Bionoid Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bionoid Pharma Enterprise Value Related Terms

Thank you for viewing the detailed overview of Bionoid Pharma's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Bionoid Pharma (Bionoid Pharma) Business Description

Traded in Other Exchanges
N/A
Address
433 N Camden Dr, Beverly Hills, CA, USA, 90210
Bionoid Pharma Inc is a cannabis company that cultivates, extracts, tests, and distributes organic hemp, cannabinoid, and related products. Its products aid in decreasing pain, improving recovery time, enhancing performance, and enhance physical well-being.